Scientists have created a vaccine that helps the body resist gaining fat. This new weekly injection works by reducing harmful ...

The mother, who resides in Campbell Hall, says his two older siblings had documented, severe reactions to the vaccine – ...

Merck Chairman and CEO Robert Davis joins 'Mad Money' host Jim Cramer at the JPMorgan Healthcare Conference to talk recent ...

Given the high cancer burden in Nigeria, the Nigerian Cancer Society,NCS, has appealed to the federal government to raise the N150 million allocated to the Cancer Health Fund,CHF,in the 2025 national ...

This top pharmaceutical stock was a massive winner in the COVID-19 vaccine sweepstakes but has been beaten down over the last three years as many are not getting boosters. Pfizer Inc. (NYSE ...

Jack Bogle created the Vanguard index investing approach as he saw "intermediaries" like brokers managers of actively managed funds added no value and impacted returns with their high costs.

Vanguard CDs are reserved for customers of the brokerage firm. They can be opened with a $1,000 minimum deposit and purchased in $1,000 increments. Vanguard charges no fees for new brokered CDs. T ...

Scientists and vaccine-makers broke speed records developing COVID-19 vaccines that have saved tens of millions of lives worldwide – and were the critical step to getting life back to normal.

How is Pennsylvania’s medical industry responding? Researchers at the University of Pennsylvania are working on a vaccine to protect humans and animals from the H5N1, or avian flu, virus.

Since late 2020, COVID-19 vaccines have been relied on to protect against severe outcomes in the presence of circulating variants of concern (VOC). Objective: This surveillance report provides a ...

The Vanguard Russell 2000 ETF (NASDAQ ... Vaxcyte, on the other hand, is a California-based developer of vaccines, and Applied Industrial Technologies is a distributor of bearings, transmission ...

Today it is driving efforts to create a new generation of therapies known as “cancer vaccines” that aim to train the immune system to recognise tumours and fight their spread. Trials are now ...